Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.10.2 (
focal adhesion kinase
)
44,029
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The subrenal capsule assay for cancer chemotherapy was performed, using tumor-specimens of 19 patients' cancers. Twelve tumor-specimens were implanted simultaneously under the renal space of immunocompetent CDF1 mice, cyclosporin A (CsA) 60 mg/kg treated mice, and BALB/c-nu/nu (nude) mice. The persistence and growth of implanted tumor-xenografts of each mouse, was evaluated, on day 6 and 9 after inoculation. The tumor-xenografts implanted under the renal space of immunocompetent mice, grew larger on days 6 in 9 cases, but histological evaluation showed tumor tissues were in various degree replaced by host reactive tissues. Host reaction in CsA-treated mice or nude mice was suppressed almost completely, but the persistence and proliferation of tumor-xenografts of both mice was varied, depending on the nature of original tumors. The judgment for cancer chemotherapy on our modified
SRC
assay was almost similar between CsA-treated mice and nude mice, but there were some cases in which macroscopical judgment didn't correspond with histological effect. The DNA synthesis of tumor-xenografts of 7 patients, was examined by using sequential changes of BrdU labeling index (LI) in the renal space of CsA-treated mice. It was showed LI rather indicated the nature of original tumors itself.
...
PMID:[The persistence and proliferation of tumor-xenografts implanted under the renal capsule of immunocompetent mice, cyclosporin A-treated mice and nude mice]. 235 85
The enzyme dextranase could degrade antigenic dextran in vivo even when given 6-15 d after the antigen. Dextranase injected after the antigen suppressed the immune response when given 24 but not 48 h after the antigen, indicating that the antigen must interact with the immune system for 48 h to initiate a response. Thereafter, the B cells are independent of further antigen stimulation. To show whether antibody-mediated suppression of the immune response was determinant specific FITC-conjugated
SRC
were applied as immunogen and antibodies were raised both against the carrier (
SRC
) and the FITC hapten. When these antibodies were injected 1-3 h after the immunogen they only suppressed the immune response to the corresponding determinant. Anti-carrier antibodies usually enhanced the response to the hapten. Therefore, antibody-mediated suppression of the immune response is determinant-specific and cannot be mediated in vivo to a detectable extent by the Fc part of the antibodies.
...
PMID:Role of antigen and antibody in the regulation of the immune response. 240 79
When CBA X BALB/c mice are immunized with Th 1 hybrid prepared by fusing spleen cells from Dx-immunized mice with the AKR thymoma BW 5147, which secretes material that affects the anti-Dx response in CBA mice, antibodies are produced that in the ELISA are shown to bind to the material secreted by Th 1 but not to the material secreted by parent BW 5147. A fraction of the Th 1 secreted material that starts eluting on DEAE chromatography in 20 nM Tris with 0.13 M NaCl is shown to bind to Dx but not
SRC
or uncoated ELISA plates. This binding, like that of anti-Dx Ig, can be inhibited with 1-10 micrograms/ml concentrations of free Dx. However, the affinity of the product of Th 1 for Dx is apparently lower than that of anti-Dx Ig, since high concentrations of anti-Dx interfere with the binding of Th 1 products to Dx. On gel permeation chromatography, a similar Dx binding material elutes in two molecular weight areas, a high area of the molecular weight of IgG and less and a low area of the molecular weight of 43,000 and above, and both are found in samples of Th 1 ascites and hyperimmune CBA anti-Dx serum, but not (or less so) in normal CBA serum and not in the hyperimmune nude C57B1 anti-Dx serum. The Th 1-derived material that affected the anti-Dx response in previously shown experiments had similar elution characteristics. Since we also show that these fractions need not to contain Ig and that anti-Th 1 minimally cross-reacts with anti-Dx IgM or IgG, it is likely that that fraction of Th 1-secreted material represents a Dx-binding, non-Ig, anti-Dx response-regulating factor.
...
PMID:ELISA assay for the detection of a dextran-binding product secreted by a T-cell hybrid Th 1. 243 47
Temporary B-cell tolerance to the trinitrophenyl (TNP) hapten can be produced in BDF1 mice by intraperitoneal injection of trinitrobenzene sulfonic acid (TNBS). Antigen-binding cells (ABC) specific to TNP, measured as TNP donkey erythrocyte rosettes, are found in tolerant mice as well as in immune mice. We have studied the surface immunoglobulin isotype profile of these TNP-binding lymphocytes (TNP-ABC) in four groups of animals: nonimmune, immune, tolerant, and tolerant-challenged. Immune mice received intravenous TNP sheep erythrocytes (TNP-SRC), whereas tolerant-challenged mice received TNP-
SRC
and TNBS on Day 0. TNP-ABC from mice immunized with TNP-
SRC
exhibit increased expression of surface IgG and decreased expression of surface IgD, compared to the ABC from nonimmune mice. Tolerant mice have a higher proportion of ABC with surface IgG, and a lower proportion with surface IgD, than nonimmune mice. Tolerant-challenged mice have a lower proportion of ABC with surface IgG, and a higher proportion with surface IgD, than immune mice. Thus, B-cell tolerance in this model entails an attenuation of the surface immunoglobulin isotype switch (loss of IgD and gain of IgG) on ABC seen in the normal immune response. For most TNP-ABC, tolerogen exposure prevents the switch in surface isotypes normally induced by exposure to TNP antigen; i.e., the tolerance lesion precedes the surface isotype switch. However, a minority of the TNP-ABC appear to switch surface isotypes in response to the tolerogen itself.
...
PMID:Abnormal expression of surface immunoglobulin isotypes on antigen-binding B lymphocytes from mice tolerant to trinitrophenyl determinants. 243 12
We have studied the specificity of the products of a "T-cell" hybridoma, Th 1, a fusion product of AKR thymoma BW 5147 with spleen cells from Dx-hyperimmunized mice, which has been shown to affect the anti-Dx but also the anti-
SRC
response from culture supernatants and ascitic fluids. The anti-Dx-affecting material was separated from unspecific effector molecules by Sephadex affinity chromatography combined with HPLC DEAE chromatography and gel filtration. The activities of fractions were tested for their effects on anti-Dx, anti-
SRC
, and anti-SSS-III IgM responses. We show that the anti-Dx response-affecting material binds to Sephadex. Its Ig contamination can be reduced by two DEAE chromatographies at pH 6 and 8.1. At pH 8.1 it starts eluting with 0.13 M NaCl, but is still contaminated with materials that affect the anti-
SRC
and to a smaller extent the anti-SSS-III response. On gel filtration it localizes in the area of 100-40 kDa. The effects of the active material on anti-Dx IgM varied from suppression to enhancement. The details of that effect are largely unknown but three other findings further confirm the Dx specificity of Th 1 products. The growth of Th 1 in mice induces the production of anti-Dx IgA, detectable in their sera with ELISA. The priming of mice with Th 1 products affects the magnitudes of anti-Dx IgM PFC responses to the subsequent immunization with Dx with or without the product. The binding to Dx of material from in vivo active fractions can be verified in the ELISA with an antiserum produced against Th 1.
...
PMID:Anti-alpha 1-6 epitope, specificity of a T-cell hybrid-secreted factor: affinity- and ion-exchange chromatographic separation. 245 2
I studied fundamentally 6-days subrenal capsule assay, using human oral cancer transplanted in nude mice. The relative variation of tumor size (delta TS/TSO) was calculated as follows; delta TS/TSO = (TS6-TSO)/TSO X 100(%), where TS 6 was the tumor size on day 6 and TSO that on day O, and more than a 10% decrease of delta TS/TSO in the treated group was considered as positive for chemosensitivity. The chemosensitive rates were 38.0 +/- 8.1% (mean +/- standard deviation) for control, -8.0 +/- 8.5% for 5-FU, 1.8 +/- 16.7 for PEP, 5.0 +/- 9.1% for CDDP, -26 +/- 9.6% for 5-FU + PEP and -17.0 +/- 6.7% for 5-FU + CDDP. A single chemotherapy was negative, but combination chemotherapy was positive and few side effects (body weight loss) was showed. The 6-days
SRC
assay (combined anticancer drugs) appeared to be useful for selecting sensitive drugs for oral cancer patient.
...
PMID:[Experimental chemotherapy using transplantable human oral cancer in nude mice by SRC assay]. 248 5
In situ hybridization of the pHul-c-src probe to metaphase cells from three normal donors and two leukemic patients showed significant labeling in the proximal region of the long arm of chromosome 20q, with modal peaks of grains consistently at band 20q11.2. A secondary peak of grains was detected in the region 20q13.2-qter, the localization of
SRC
suggested by previous in situ studies. The exact localization of
SRC
is important for understanding the del(20q) chromosomal abnormality in myeloid neoplasias. Chromosome in situ hybridization and genomic studies showed loss of one allele of
SRC
in two patients with the deletion (20q). These results differ from previously published findings and suggest heterogeneity of the breakpoint at 20q11.2 in interstitial deletions of 20q, which characterize myeloid disorders.
...
PMID:Localization of the SRC oncogene to chromosome band 20q11.2 and loss of this gene with deletion (20q) in two leukemic patients. 250 51
In pulmonary fibrosis the connective tissue framework and the mechanical properties of the lung are profoundly altered. Changes in amounts or distributions of each component of lung tissue (collagen, elastin, and ground substance such as glycosaminoglycans) might be expected to produce changes in viscoelastic properties of lung parenchyma and lead to mechanical inefficiency of the lungs. In order to evaluate the viscoelastic properties of the alveolar wall of fibrotic lungs, we analysed stress relaxation curves (SRL) of lung tissue in hamsters. Golden hamsters were divided into two groups: control (group C) and a group treated intratracheally with bleomycin (group B). Small piece of the alveolar wall tissue (80 x 80 x 1000 microns) was extended, and
SRC
was recorded for 3 minutes at the fixed extended length. Relaxation times (Tm) were used as indices of tissue viscoelastic properties. Three different Tm (Tm1: short, Tm2: moderate, and Tm3: long relaxation times) were obtained using the method of residuals. In group B, Tm3 (long relaxation time) was significantly larger than Tm3 in the other. Our results in relaxation time suggested that alveolar walls become more viscous with fibrosis. This rise in tissue viscosity with fibrosis may have been due to altered properties of the increased elastic fibers.
...
PMID:[Viscoelastic properties of the alveolar wall in experimental pulmonary fibrosis]. 258 99
N-Myristoyl transferase (NMT) activity was measured in rat liver and H9 cells using an in vitro assay based on acylation of synthetic peptides. Glucosamine was found to inhibit the NMT activity. Using a synthetic peptide mimicking the N-terminus of HIV p27nef a Km value of 2.4 microM and a Vmax of 240 pmol/mg per h was found. In the presence of glucosamine the Vmax was lowered indicating that glucosamine acted as a non-competitive inhibitor. Glucosamine also inhibited incorporation of radiolabelled myristic acid into H9 cell proteins in vivo. In liver cells using a peptide from the N-terminus of p60
SRC
only the Vmax was affected.
...
PMID:Inhibition by glucosamine of myristoylation in human H9 lymphocytes and rat liver cells. 268 32
It is clear that if we could predict a sensitive drug against an individual tumor the therapeutic effect would be much improved. For this purpose, many kinds of chemosensitivity test have been devised and investigated. The five kinds of test used currently are based on the measurement of enzyme activities (enzyme assay), measurement of inhibition of radioactive precursors incorporation, and measurement of clonogenic cells in a tumor cell population. In vivo assay systems are xenografts of human tumor in nude mouse and the subrenal capsule of the mouse (
SRC
assay). In vivo and in vitro correlations reported by several authors are summarized in which positive predictivity rate revealed around 50% and negative 90%. Among five kinds of chemosensitivity test enzyme assay and
SRC
assay are recommended for clinical use.
...
PMID:[Assessment of chemosensitivity tests of human tumor cells]. 273 32
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>